Conventional antipsychotics can be cost effective for broadly defined treatment resistant or intolerant schizophrenia [Abstract]

Linda Davies, Shon Lewis, Karen Hayhurst

Research output: Contribution to journal › Meeting Abstract

2 Article

2 results

Filter

2007
Cost-effectiveness of first- v. second-generation antipsychotic drugs: Results from a randomised controlled trial in schizophrenia responding poorly to previous therapy
Davies, L. M., Lewis, S., Jones, P. B., Barnes, T. R. E., Gaughran, F., Hayhurst, K., Markwick, A. & Lloyd, H., Jul 2007, In: British Journal of Psychiatry. 191, JULY, p. 14-22 8 p.
Research output: Contribution to journal › Article › peer-review
2006
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment
Lewis, S. W., Davies, L., Jones, P. B., Barnes, T. R. E., Murray, R. M., Kerwin, R., Taylor, D., Hayhurst, K., Markwick, A., Lloyd, H. & Dunn, G., May 2006, In: Health Technology Assessment. 10, 17, p. 1-165 165 p.
Research output: Contribution to journal › Article › peer-review

Open Access